CONMED CORPORATION Operating Leases, Rent Expense
CONMED CORPORATION (CNMD) reported Operating Leases, Rent Expense of $8.70 million for the 12-month period ending 2018-12-31, per its 10-K filed 2021-02-22.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2021-02-22
- CONMED CORPORATION operating leases, rent expense for fiscal 2018 was $8.70M, a 33.85% increase from fiscal 2017.
- CONMED CORPORATION operating leases, rent expense for fiscal 2017 was $6.50M, a 8.33% increase from fiscal 2016.
- CONMED CORPORATION operating leases, rent expense for fiscal 2016 was $6.00M, a 9.81% increase from fiscal 2015.
- CONMED CORPORATION operating leases, rent expense for fiscal 2015 was $5.46M, a 7.34% decline from fiscal 2014.
| Period end | Operating Leases, Rent Expense 12 month | Operating Leases, Rent Expense 12 month as first filed |
|---|---|---|
| 2018-12-31 | $8.70M 10-K · filed 2021-02-22 | |
| 2017-12-31 | $6.50M 10-K · filed 2020-02-24 | $6.51M 10-K · filed 2018-02-26 |
| 2016-12-31 | $6.00M 10-K · filed 2019-02-25 | $6.04M 10-K · filed 2017-02-27 |
| 2015-12-31 | $5.46M 10-K · filed 2018-02-26 | |
| 2014-12-31 | $5.90M 10-K · filed 2017-02-27 | |
| 2013-12-31 | $6.71M 10-K · filed 2016-02-23 | |
| 2012-12-31 | $6.42M 10-K · filed 2015-02-23 | |
| 2011-12-31 | $6.22M 10-K · filed 2014-02-24 | |
| 2010-12-31 | $5.83M 10-K · filed 2013-02-25 | |
| 2009-12-31 | $5.99M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |